TY  - GEN
AU  - Osaka,Rie
AU  - Muraoka,Yuki
AU  - Miwa,Yuko
AU  - Manabe,Koichiro
AU  - Kobayashi,Mamoru
AU  - Takasago,Yukari
AU  - Ooto,Sotaro
AU  - Murakami,Tomoaki
AU  - Suzuma,Kiyoshi
AU  - Iida,Yuto
AU  - Tsujikawa,Akitaka
TI  - Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema following Central Retinal Vein Occlusion: 1 Initial Injection versus 3 Monthly Injections
SN  - 1423-0267
PY  - 2018///0202
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Angiogenesis Inhibitors
KW  - administration & dosage
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Female
KW  - Fluorescein Angiography
KW  - Follow-Up Studies
KW  - Fundus Oculi
KW  - Humans
KW  - Intravitreal Injections
KW  - Macula Lutea
KW  - pathology
KW  - Macular Edema
KW  - diagnosis
KW  - Male
KW  - Middle Aged
KW  - Prospective Studies
KW  - Ranibizumab
KW  - Retinal Vein Occlusion
KW  - complications
KW  - Time Factors
KW  - Tomography, Optical Coherence
KW  - Treatment Outcome
KW  - Vascular Endothelial Growth Factor A
KW  - antagonists & inhibitors
KW  - Visual Acuity
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.1159/000479049
ER  -